Parametric Portfolio Associates’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.49M | Buy |
45,505
+28,043
| +161% | +$919K | ﹤0.01% | 2574 |
|
|
2021
Q4 | $460K | Sell |
17,462
-34,726
| -67% | -$915K | ﹤0.01% | 3109 |
|
|
2021
Q3 | $5.25M | Sell |
52,188
-9,294
| -15% | -$935K | ﹤0.01% | 1793 |
|
|
2021
Q2 | $8.7M | Buy |
61,482
+8,346
| +16% | +$1.18M | ﹤0.01% | 1487 |
|
|
2021
Q1 | $5.3M | Buy |
53,136
+2,733
| +5% | +$272K | ﹤0.01% | 2124 |
|
|
2020
Q4 | $6.23M | Buy |
50,403
+30,006
| +147% | +$3.71M | ﹤0.01% | 1925 |
|
|
2020
Q3 | $1.99M | Sell |
20,397
-3,354
| -14% | -$327K | ﹤0.01% | 2509 |
|
|
2020
Q2 | $3.71M | Buy |
23,751
+1,650
| +7% | +$257K | ﹤0.01% | 2093 |
|
|
2020
Q1 | $3.19M | Sell |
22,101
-5,564
| -20% | -$803K | ﹤0.01% | 2065 |
|
|
2019
Q4 | $5.66M | Buy |
27,665
+9,390
| +51% | +$1.92M | ﹤0.01% | 1968 |
|
|
2019
Q3 | $1.47M | Sell |
18,275
-13,428
| -42% | -$1.08M | ﹤0.01% | 2818 |
|
|
2019
Q2 | $2.99M | Buy |
31,703
+1,318
| +4% | +$124K | ﹤0.01% | 2385 |
|
|
2019
Q1 | $2.6M | Buy |
30,385
+9,616
| +46% | +$822K | ﹤0.01% | 2491 |
|
|
2018
Q4 | $1.17M | Buy |
20,769
+955
| +5% | +$53.6K | ﹤0.01% | 2888 |
|
|
2018
Q3 | $1.62M | Buy |
+19,814
| New | +$1.62M | ﹤0.01% | 2845 |
|